Myeloma 2017 | Where no man has gone before: the technologies being used to explore MM epigenetic factors
In recent years, researchers have become increasingly aware of the fact that epigenetic alterations can contribute to the formation of multiple myeloma (MM); however, our understanding of these remain unclear. In this interview, Felipe Prosper Cardoso, MD, of the University of Navarra, Pamplona, Spain, gives an insightful overview of the high-throughput technologies currently being used to investigate these epigenetic mechanisms, including ChIP-sequencing, chromosome conformation capture-on-chip (4C), and bisulfite sequencing. This video was recorded at the Myeloma 2017 meeting, held in Edinburgh, UK.
Get great new content delivered to your inboxSign up